Professional
Added to YB: 2024-12-18
Pitch date: 2024-12-17
HIMS [bullish]
Hims & Hers Health, Inc.
-35.13%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$31.34
Price Target
42.00 (+107%)
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
growth
Hims & Hers (HIMS): Morgan Stanley Sets $42 Target Amid Strong Growth Projections
HIMS: Morgan Stanley initiates Overweight, $42 PT. 30% rev CAGR 2024-26, 80% GM. Strong mgmt from Uber, Netflix, FDA. Personalization driving 175% y/y subscriber growth. PT based on 3.5x CY26 EV/S, 24x EV/EBITDA. Bull/Bear case skew 2.5:1. Estimates 5%/9% above Street for 2025 rev/EBITDA.
Read full article (1 min)